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Abstract
Introduction: The incidence of cancer is increasing worldwide and with it the prevalence of malnutrition, which is
responsible for the death of almost 20 % of cancer patients. The objective of this study was to identify the factors
associated with malnutrition in hospitalized cancer patients.
Methods: Cross-sectional study conducted with 277 hospitalized patients in the Institute of Integrative Medicine
Prof. Fernando Figueira from March to November 2013. The nutritional status was classified as well-nourished and
moderate/severe malnutrition, according to the Patient-Generated Subjective Global Assessment. The association
between moderate/severe malnutrition and demographic, behavioral, socioeconomic, clinical, therapeutic and
nutritional variables was investigated through univariate regression and hierarchical Poisson models, with a 5 %
significance level.
Results: The prevalence of malnutrition was 71.1 %, being classified as moderate in 35.4 % and severe in 35.7 %. After
multivariate analysis, smokers/ex-smokers low socioeconomic status, performance status ≥2 and age ≥60 years were
associated with increased risk of malnutrition.
Conclusion: There was observed a high prevalence of moderate/severe malnutrition in cancer patients, with the
increased risk of malnutrition associated with the presence of factors that can be assessed during hospital admission
suggesting a higher alert of the medical and health care staff about the need for nutritional assessment and
intervention.
Keywords: Nutrition assessment, Risk factors, Malnutrition, Cancer
Introduction
The incidence of cancer is increasing worldwide and
with it the prevalence of malnutrition, which may vary
between 40 and 80 % in patients with neoplasia [1, 2].
The cancer is responsible for approximately 13 % of all
causes of death worldwide, however the death of almost
20 % of cancer patients occurs as a result of malnutrition
and its complications, rather than the malignancy of the
disease itself [3, 4].
In Brazil, a multicenter study found a prevalence of
malnutrition of 66.3 % and an increased risk of almost
three-fold of malnutrition (20.3 %) among cancer pa-
tients [5]. A similar result was found in a study con-
ducted in Latin America with hospitalized patients,
which showed a prevalence of 65.6 % of malnutrition in
individuals with cancer [6].
The etiology of malnutrition in cancer patients is com-
plex and multifactorial and may be influenced by the lo-
cation and type of tumor, stage of the disease, side
effects of the treatment, socioeconomic status, func-
tional performance, symptoms of nutritional impact,
need for fasting and inadequate nutritional therapy, as
well as medical staff awareness about the importance of
nutritional status for the prognosis and quality of life of
hospitalized patients [5–8].
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In patients with cancer, a risk up to 30 % of malnutri-
tion among hospitalized patients in older age (OR 1.38;
IC 95 %: 1.28 – 1.54) [6] and almost three-fold in pa-
tients with low functional performance [3] were ob-
served. Another study found that smoking is associated
with the need for enteral nutrition therapy in patients
with head and neck cancer, suggesting that is also associ-
ated with depletion of the nutritional status, because this
therapy is used when there is a partial or total im-
pairment of food intake. However, these factors are
not well elucidated [9].
The identification of factors that can be assessed dur-
ing the hospital admission can alert the medical and
healthcare staff about the need for evaluation and early
nutritional intervention to avoid further complications.
Researches show that malnutrition is associated with
lower response and tolerance to antineoplastic treat-
ment; reduction in the quality of life; higher morbidity,
mortality and infectious complications and an increase
in length of hospital stay and costs by reducing the avail-
ability of hospital beds and consequently the number of
patients attended [3, 10].
The objective of this study was to determine the
prevalence and factors associated with malnutrition in
hospitalized cancer patients so they can be identified at
hospital admission and possible complications from mal-
nutrition avoided.
Methods
Cross-sectional study, performed between March and
November 2013, in oncology and palliative care in-
patient units of the Institute of Integrative Medicine
Prof. Fernando Figueira (IMIP), referral center for oncol-
ogy in northeastern Brazil, located in Recife, Pernam-
buco. The study started after its approval by the Ethics
Committee on Human Research of the cited institution
under protocol 10241612.7.0000.5201.
Patients with cancer of both sexes and aged 18 and
older participated in the study. Those patients hospital-
ized for more than 72 h, who where fed exclusively
through catheter or ostomies for more than 72 h, with
consumptive disorders or pregnant were excluded from
the sample.
The sample size was calculated using the Statcalc func-
tion of the Epi-Info 3.5.3 program (Centers for Disease
Control and Prevetion, Atlanta, GA, EUA). Considering a
frequency of malnutrition in cancer patients of 30 % [3], a
significance level of 5 %, an 80 % power and a relative
accuracy of 20 %, would be necessary 224 individuals.
Foreseeing possible losses, the sample was increased by
20 % to 277 volunteers.
The selection and evaluation of the participants were
performed by a single trained nutritionist. After the sign
of an Informed Consent Form, by the patient or legal
guardian, were collected demographic, behavioral and
socioeconomic variables [age (years), gender, origin,
marital status, occupation, smoking, education, and so-
cioeconomic class]; nutritional variables [symptoms of
nutritional impact, current weight (kg), habitual weight
(kg), height (m), weight loss percentage and previous
body mass index (kg/m2)]; clinical variables (type of can-
cer, presence of metastasis and performance status) and
therapeutic variables (previous treatment and type of an-
ticancer treatment).
Demographic, behavioral and socioeconomic variables
were collected according to the report of the patient and
medical record and socioeconomic class and education
were obtained from the Brazilian Association of Re-
search Companies questionnaire (ABEP) [11]. According
to the ABEP questionnaire, family income is classified in
five levels, being A the highest and E the lowest socio-
economic level. For analysis purposes, the extremes of
socioeconomic levels were grouped to form three cat-
egories: A and B; C; D and E [11].
To obtain the anthropometric variables (current weight
and height) the patient was measured twice and if there
was difference between these values a third measure was
made and then calculated the average and recorded the
final value [12]. To measure these variables it was used a
fixed vertical digital platform scale with stadiometer
(FILIZOLA™, São Paulo, Brazil) with a variation of
50 g, capacity up to 200 kg and 0.5 cm precision. If
there was no possibility of measuring the stature, it
was estimated from the Chumlea equation [13]. Habitual
weight (HW) of the last six months was obtained accord-
ing to the report of the patient.
The weight loss percentage (%WL) was calculated
from the equation [(habitual weight - current weight)/
habitual weight × 100], considering the cutoff point of %
WL ≥5 on the past six months [14–16]. The previous
body mass index (pBMI) was obtained by the equation
(habitual weight/height2) and was classified according to
the recommendations of the World Health Organization
(WHO) for adults and the Pan American Health
Organization (PAHO)/WHO for elderly [12, 17]. This
variable was stratified into two categories correspond-
ing to overweight (overweight and obese) and normal
weight (normal weight and malnutrition).
Nutritional diagnosis was obtained through the scored
Patient-Generated Subjective Global Assessment (PG-
SGA), which consists of a tool used for screening and
nutritional diagnosis of cancer patients developed for
Ottery [14] and validated in Portuguese by Gonzalez
et al. [15]. This questionnaire allows not only classify the
nutritional assessment into three categories (A = well
nourished, B = suspected or moderate malnutrition and
C = severe malnutrition), but also generates a numerical
score which enables the selection of the appropriate level
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of nutritional intervention [14, 15]. For statistical ana-
lysis, the participants who were in categories B and C
were classified as malnourished nutritional status. The
presence of symptoms of nutritional impact was also ob-
tained from this questionnaire.
Clinical variables were collected in medical records,
but the performance status (PS) was obtained from the
scale developed by the Eastern Cooperative Oncology
Group (ECOG) [18], that ranks the functional capacity
in five levels, being the zero, the fully active individual
and the four, the bedridden and unable to perform self-
care activities individual. Considering that the limited
functional capacity leads to difficulties in preparing and
food intake, this variable was stratified in PS <2 and PS ≥2,
because PS = 2 indicates inability to perform any work
activity [19, 20].
For analysis, the cancers were stratified into six groups
according to the location of the tumor (upper gastro-
intestinal tract, lower gastrointestinal tract, reproductive
tract, lung, breast and other cancers). The cancers be-
longing to the latter class were those who do not fit into
any of the former classifications.
Regarding therapeutic variables, the types of treatment
were stratified into clinical treatment, when the individ-
ual has been subjected to at least one radiotherapy and/
or chemotherapy session; surgical treatment, when any
procedure for complete or partial resection of the tumor
mass was conducted; medical/surgical treatment, when
both treatments were needed; and palliative treatment
when the therapy performed had no more intention of
healing.
In order to avoid bias, the evaluations were performed
by a single trained examiner and the questions asked in
the same way for all studied individuals. The PG-SGA
was preferably the first evaluation to be conducted. Before
the anthropometric measurements the calibration of the
instruments was always checked.
Categorical variables were presented by absolute and
relative frequencies and the continuous variables were
summarized using the central tendency and dispersion
measures. The association between malnutrition and
analytical variables was performed by the Poisson regres-
sion model, assuming a significance level of p <0.05. To
adjust the effect of independent predictors for malnutri-
tion, all variables were included in a new hierarchical
Poisson regression model, adopting a significance level
of 5 %, a 95 % confidence interval and a power of 80 %.
Data analyses were conducted through STATA 12.1SE
program (Stata Corporation, College Station, TX, USA).
Results
During the study period 480 cancer patients were admit-
ted, being 203 ineligible by exclusion criteria. Thus, 277
patients were eligible and all agreed to participate.
More than half of the sample (56.0 %) were female.
The mean age was 54.7 ± 14.9 years, with 39.4 % (n =
109) of patients aged ≥60 years. Most individuals
(60.3 %) had a partner and 37.9 % came from the coun-
tryside of Pernambuco. In relation to scholarity, 40.1 %
had not finished elementary school. The results showed
that most of the study population belonged to the lower
social classes: Class C (52.7 %); and classes D and E
(23.8 %). Most (61.0 %) were retired or had illness bene-
fit and 14.1 % worked (Table 1).
The types of cancers, classified by the organic system,
most frequently affected were the lower gastrointestinal
tract (LGIT) (20.9 %) and reproductive system (18.8 %).
Although the majority of patients (62.1 %) had received
any type of curative treatment, half of them (50.2 %) had
metastatic tumors. The sample showed a considerable
prevalence of impaired physical performance (46.2 %), be-
ing more prevalent in tumors of the reproductive system,
as well as the symptoms of nutritional impact (Table 2).
Table 1 Sociodemographic characteristics of the sample
Characteristics N(%)
Marital status
With partner 167 (60.3)





Another states 7 (2.5)
Scholarity
Unlettered 40 (14.4)
Incompleted elementary school 111 (40.1)
Completed elementary school 28 (10.1)
Completed high school 82 (29.6)
Completed undergraduation 16 (5.8)
Socioeconomic class
A and B 65 (23.5)
C 146 (52.7)
D and E 66 (23.8)
Ocupation






Never smoke 139 (50.2)
aRecife metropolitan area
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The prevalence of malnutrition was 71.1 %, with simi-
lar frequencies between moderate (35.4 %) and severe
malnutrition (35.7 %). In relation to the types of cancer,
severe malnutrition was more prevalent in patients with
cancer of the upper gastrointestinal tract (28.3 %). Of
the 126 patients who remembered the usual weight,
80.2 % had %WL ≥5 in the last 6 months with a median
of 14.7, whereas in tumors classified as others, 24.8 %
had WL% ≥5 in the last 6 months (Table 2).
Univariate analysis revealed that smokers/ex-smokers,
socio-economic classes C, D and E, tumors of the
upper gastrointestinal tract and lung, patients who had
not cancer treatment, palliative care, PS ≥2, individuals
without a prior excess of weight and age ≥60 years
were associated with the presence of malnutrition
(Table 3).
In multivariate analysis the factors that remained sig-
nificantly associated with malnutrition were: smokers/
ex-smokers, socio-economic classes C, D and E, PS ≥2
and age ≥60 years (Table 4).
Discussion
In this study, according to PG-SGA, more than half of
the sample had some degree of malnutrition, being simi-
lar to the frequency of moderate and severe malnutri-
tion, 35.4 and 35.7 %, respectively. The factors that
independently associated to this nutritional disorder
were smokers/ex-smokers, socio-economic classes C, D
and E, PS ≥2 and age ≥60 years.
The high prevalence of malnutrition found in our
study is not surprising, considering that hospitalized
cancer patients are more likely to have some level of nu-
tritional disability compared to other hospitalized indi-
viduals [5, 6]. We must consider that the hospitalization
prior to the period of the study was not an exclusion cri-
terion in our research and this may have influenced the
Table 2 Sample characteristics according to the types of cancer
Type of cancer
Characteristics Total sample UGITa LGITb RSc Lung Breast Othersd
Type of cancer - n (%) 277 (100) 43 (15.5) 58 (20.9) 52 (18.8) 32 (11.6) 30 (10.8) 62 (22.4)
Age - Mean (SD) 54.7 (14.9) 57.6(13.3) 57.6 (12.9) 52.9 (15.3) 57.7 (13.8) 56.6 (15.5) 48.8 (16.2)
≥60 - n (%) 109 (39.4) 20 (18.3) 29 (26.6) 19 (17.4) 13 (11.9) 12 (11.0) 16 (14.7)
Gender - n (%)
Male 122 (44.0) 23 (18.9) 20 (16.4) 15 (12.3) 21 (17.2) 0 (0.0) 43 (35.2)
Female 155 (56.0) 20 (12.9) 38 (24.5) 37 (23.9) 11 (7.1) 30 (19.4) 19 (12.3)
Metastasis - n (%)
Absent 138 (49.8) 15 (10.9) 29 (21.0) 26 (18.8) 11 (8.0) 19 (13.8) 38 (27.5)
Present 139 (50.2) 28 (20.1) 29 (20.9) 26 (18.7) 21 (15.1) 11 (7.9) 24 (17.3)
Performance status - n (%)
<2 149 (53.8) 20 (13.4) 36 (24.2) 23 (15.4) 14 (9.4) 17 (11.4) 39 (26.2)
≥2 128 (46.2) 23 (18.0) 22 (17.2) 29 (22.7) 18 (14.1) 13 (10.2) 23 (18.0)
Symptoms of impact - n (%)
Yes 186 (67.1) 31 (16.7) 35 (18.8) 39 (21.0) 26 (14.0) 17 (9.1) 38 (20.4)
No 91 (32.9) 12 (13.2) 23 (25.3) 13 (14.3) 6 (6.6) 13 (14.3) 24 (26.4)
%WL ≥5 em 6 meses - n (%)
Yes 101 (80.2) 20 (19.8) 21 (20.8) 15 (14.9) 15 (14.9) 5 (5.0) 25 (24.8)
No 25 (19.8) 2 (8.0) 5 (20.0) 7 (28.0) 1 (4.0) 4 (16.0) 6 (24.0)
Overweight (pBMI) - n (%)
Yes 76 (60.3) 14 (18.4) 12 (15.8) 15 (19.7) 12 (15.8) 4 (5.3) 19 (25.0)
No 50 (39.7) 8 (16.0) 14 (28.0) 7 (14.0) 4 (8.0) 5 (10.0) 12 (24.0)
PG-SGA - n (%)
Well nourished 80 (28.9) 7 (8.8) 19 (23.8) 13 (16.3) 5 (6.3) 13 (16.3) 23 (28.8)
Moderate malnutrition 98 (35.4) 8 (8.2) 21 (21.4) 21 (21.4) 17 (17.3) 12 (12.2) 19 (19.4)
Severe malnutrition 99 (35.7) 28 (28.3) 18 (18.2) 18 (18.2) 10 (10.1) 5 (5.1) 20 (20.2)
SD standard deviation, PS performance status, %WL weight loss percentage, PG-SGA patient-generated subjective global assessment; aUpper gastrointestinal tract:
esophagus, stomach, pancreas, liver, gallbladder, biliary ducts; bLower gastrointestinal tract: colon, rectum and anal canal; cReproductive system: ovarian, cervical,
testicular and prostate; dHead and neck, hematological, unknown primary site, sarcoma, melanoma
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high prevalence. However, our results were similar to
two Brazilian cross-sectional studies, which found a mal-
nutrition prevalence of 66.3 and 77.8 %, although they
used for nutritional diagnosis the Subjective Global
Assessment (SGA) [5, 21] different from our study that
used the PG-SGA. Equivalent results were also obtained
in Latin America (65.6 %), South Korea (61.3 %) and
Australia (76.0 %) [2, 6, 22].
In relation to lower prevalences of malnutrition in
cancer patients, were found two other Brazilian studies,
with frequencies of 39.4 and 48.2 %, using the PG-SGA
as a nutritional assessment method. These results can be
justified because they are studies conducted with pa-
tients at the beginning of the chemotherapy treatment
and with more than 1/3 of the sample with tumor in
stages I or II. Different from our patients who had
50.2 % of metastatic tumors, indicating advanced stages
of disease [15, 23].
The most common method for initial nutritional as-
sessment in cancer patients was the ASG [5, 21], how-
ever, nowadays this tool is not well recommended.
Because the incorporation of prognostic indicators such
Table 3 Unadjusted analysis of factors associated with malnutrition
Variables Total sample Malnutrition PR (IC95%) p
valueN N (%)
Smoking 0.005
Smoker/ex-smoker 138 109 (79.0) 1.25 (1.07 – 1.45)
Never smoke 139 88 (63.3) 1.0
Socioeconomic class 0.003
A and B 65 36 (55.4) 1.0
C 146 106 (72.6) 1.31 (1.03 – 1.67)
D and E 66 55 (83.3) 1.50 (1.18 – 1.92)
Type of cancer 0.026
UGITa 43 36 (83.7) 1.48 (1.05 – 2.08)
LGITb 58 39 (67.2) 1.19 (0.83 – 1.70)
RSc 52 39 (75.0) 1.32 (0.93 – 1.88)
Lung 32 27 (84.4) 1.49 (1.05 – 2.11)
Breast 30 17 (56.7) 1.0
Othersd 62 39 (62.9) 1.11 (0.77 – 1.60)
Previous treatment 0.005
Absent 60 50 (83.3) 1.23 (1.06 – 1.42)
Present 217 147 (67.7) 1.0
Type of treatment <0.001
Clinicale 85 50 (58.8) 0.86 (0.62 – 1.21)
Surgical 22 15 (68.2) 1.0
Clinical e surgical 65 39 (60.0) 0.88 (0.62 – 1.25)
Palliative 45 43 (95.6) 1.40 (1.05 – 1.88)
Performance status <0.001
<2 149 84 (56.4) 1.0
≥2 128 113 (88.3) 1.57 (1.34 – 1.83)
Overweight 0.023
Yes 76 64 (84.2) 1.0
No 50 48 (96.0) 1.14 (1.02 – 1.28)
Age <0.001
<60 168 102 (60.7) 1.0
≥60 109 95 (87.2) 1.44 (1.25 – 1.65)
PR prevalence ratio, CI confidence interval, p significance level; aUpper gastrointestinal tract: esophagus, stomach, pancreas, liver, gallbladder, biliary ducts; bLower
gastrointestinal tract: colon, rectum and anal canal; cReproductive system: ovarian, cervical, testicular and prostate; dHead and neck, hematological, unknown
primary site, sarcoma, melanoma; eradiotherapy and/or quimiotherapy
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as the details of the symptoms of nutritional impact and
weight loss, which are frequently observed in patients
with cancer, to the PG-SGA, this tool is the indicated as
initial method of nutritional assessment on admission of
these individuals [9, 14, 16, 24].
It is well known that the %WL >5 in 6 months previ-
ous to the diagnosis is correlated to a lower survival rate
and when it is >10 % is associated with an increased risk
of complications due to malnutrition [14]. In our study
36.5 % of the total sample had %WL≥5 in 6 months.
This fact is a concern, because the weight loss process,
regardless of the usual weight of the individual, is
considered itself a malnutrition process, even after the
body changes, the patient remains within normal pat-
terns [12, 25].
Another characteristic prognostic indicator of the can-
cer patient is the presence of symptoms of nutritional
impact, due to its high prevalence mainly due to the
tumor itself, antineoplastic therapy introduced as well as
malnutrition [14, 15]. Our results showed that more
than half of the sample (67.1 %) had symptoms of nutri-
tional impact, in which the most prevalent were: an-
orexia (50.5 %), pain (23.1 %), vomiting (19.4 %),
constipation, and dysgeusia (17.7 %). These results agree
with Brazilian and American cross-sectional studies,
which place anorexia and pain among the most preva-
lent symptoms in their populations [22, 23].
A recent prospective study conducted in Canada on
patients with advanced cancer showed an association be-
tween the symptoms of nutritional impact (anorexia,
gastric fullness, dysgeusia, dry mouth and dysphage) and
lower survival rate on its univariate analysis, with dys-
phagia as an independent factor on its final model [26].
This fact highlights the importance of evaluation and ap-
propriate management of these symptoms, given the
large impact that causes on prognosis and quality of life
of patients.
A concerning data found was the high prevalence of se-
vere malnutrition (35.7 %), because this value is above the
presented in the literature [3, 15, 23, 27]. We could refer
the high rate to the fact that our patients were exposed to
various risk factors for malnutrition as observed in the
univariate analysis. We must also highlight the fact that
the food and nutrition insecurity can permeate many sub-
jects of our population, since a part of it belongs to lower
social classes, which is an independent risk factor for mal-
nutrition (p = 0.012) in our multivariate analysis.
The data regarding nutritional status of our patients
only reaffirm the neglect to recognize malnutrition as a
public health problem, considering that the prevalence
rates have not decreased, despite being well documented
over the past decades and its relationship with the prog-
nosis and quality of life of patients with cancer [1]. A
limiting factor in our study for this assessment is the
lack of data on early nutritional support for these pa-
tients. Although, an important move to be made is to
invest in adequate nutritional screening in order to es-
tablish an early nutritional therapy in order to prevent
deterioration of nutritional status which is already ex-
pected in hospitalized patients.
Table 4 Independent factors associated with malnutrition
Sample Outcome
Variables N N(%) RRunadjusted(CI95%) p value RRadjusted(CI95%) p value
Distal level
Smoking 0.005 0.015
Smoker/ex-smoker 138 109(79.0) 1.25(1.07 – 1.45) 1.21(1.04 – 1.40)
Never smoke 139 88(63.3) 1.0 1.0
Socioeconomic class 0.003 0.012
A and B 65 36(55.4) 1.0 1.0
C 146 106(72.6) 1.31(1.03 – 1.67) 1.30(1.02 – 1.65)
D and E 66 55(83.3) 1.50(1.18 – 1.92) 1.44(1.13 – 1.84)
Intermediate level
Performance status <0.001 <0.001
<2 149 84(56.4) 1.0 1.0
≥2 128 113(88.3) 1.57(1.34 – 1.83) 1.50(1.30 – 1.75)
Proximal level
Age <0.001 <0.001
<60 168 102(60.7) 1.0 1.0
≥60 109 95(87.2) 1.44(1.25 – 1.65) 1.36(1.19 – 1.56)
RR risk ratio, CI confidence interval, p significance level
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In this study, smoking was identified as an independ-
ent risk factor for malnutrition (p = 0.015), in agreement
with a British retrospective study that found an associ-
ation between the use of cigarettes above 20 units/day
and the necessity of use of enteral nutrition in patients
with head and neck cancer (OR 4.08; IC 95 %: 1.29 –
12.89) [9]. Among the deleterious effects of nicotine, its
action on the central nervous system leads to reduced
appetite and these individuals are also susceptible to
taste disturbance, causing a lower intake of nutrients [9,
28]. In addition, the tobacco has a thermogenic effect,
leading to weight loss [9]. Another important factor in
this relationship between smoking and malnutrition is
the economic impact of the cigarettes on family spent,
because instead of buying groceries part of the money is
spent to keep the addiction [29].
Functional autonomy is a factor that deserves atten-
tion from health professionals when the point is nutri-
tional risk indicators, considering that individuals with
limited functional capacity have difficulties in the prep-
aration and food intake [19, 30]. The results of this study
support this statement, because it was observed that the
PS ≥2 was a risk factor for malnutrition. Similar results
were found by a French epidemiological study that
found a chance of being malnourished almost three-fold
higher in cancer patients admitted with low functional
performance [3]. Similarly a multicenter cohort study
showed that this is also a risk factor for ambulatory
patients [19].
A Greek prospective study conducted with 173 pa-
tients with lung cancer showed an association between
the PS and the %WL >5 in the last 3 months (p <0.001),
with %WL as an indicative of a considerable deterior-
ation of the nutritional status [14, 16, 27]. Other results
have also shown an independent relationship of the per-
formance status with survival and death of patients with
cancer [3, 26, 31].
According to our results, elderly is a factor that in-
creases by almost 30 % the chance of malnutrition. This
association was expected, since it is well known that
advanced age predisposes to nutritional deficiencies, es-
pecially in hospitalized individuals [3, 5, 6].
The previous overweigh was not associated with mal-
nutrition in this study, most likely due to the limited
number of patients (n = 126) who remembered the usual
weight in the last 6 months. A French research showed a
significant association between prior obesity and risk of
malnutrition [3]. This finding can be explained by the
negligence in relation to the excess of weight loss by the
health care team, even knowing that the decrease in
weight can be of lean mass, resulting in a worse progno-
sis. We also highlight the knowledge that being over-
weight is a bad prognosis factor due to inadequate
dosage of medications for treatment, calculated from
body weight, and the chronic inflammatory condition of
obese patients [3, 32, 33].
The most worrying fact in obese patients might be re-
lated to the sarcopenia, characterized by a progressive
and widespread loss of lean body mass, which is asso-
ciated to a worsening of the functional status and
quality of life and death [34]. A Canadian cohort that
evaluated the sarcopenic obesity and its clinical impli-
cations in patients with solid tumors, found a preva-
lence of 15 % of sarcopenia in obese subjects (OR
4.2; 95 % CI: 2.4 – 7.2) [35].
Although it is well established in the scientific com-
munity that the types of cancer and treatment are pre-
dictive factors for malnutrition, in this study they did
not remain in the final model. Such fact occurred prob-
ably due to the small sample for this analysis, because
there were considered different types of response of
these two variables [3, 6, 7]. It is important to consider
that factors such as comorbidities, antibiotic therapy and
diagnostic time can also be associated with the outcome,
however, they were not collected and therefore are con-
sidered limiting factors of our research. It is also
highlighted that the stage of the disease was not in-
cluded on statistical analysis because the stage of tumors
of different sites is distinct.
According to the extensive search performed in the
main electronic databases, it was not found any other
study in the northeast region of the country with a simi-
lar design, exclusively with hospitalized cancer patients,
including palliative care, and using the PG-SGA. How-
ever, longitudinal studies that include larger numbers of
patients to better determine the results found in our re-
search are still needed.
Conclusion
The data presented in this study showed the high preva-
lence of malnutrition in hospitalized cancer patients.
The factors independently associated to this nutritional
disorder were smokers/ex-smokers, socio-economic clas-
ses C, D and E, PS ≥2 and age ≥60 years. Thus, the simple
perception of these factors can alert health professionals
about the risk of nutritional depletion and the need for
differentiated nutritional intervention.
Availability of supporting data
The dataset that supports the results of this paper is in-
cluded in the manuscript and its additional files.
Abbreviations
% WL: Weight loss percentage; ABEP: Brazilian Association of Research
Companies; ECOG: Eastern Cooperative Oncology Group; HW: Habitual
weight; IMIP: Institute of Integrative Medicine Prof. Fernando Figueira;
PAHO: Pan American Health Organization; pBMI: Previous body mass index;
PG-SGA: Patient-generated subjective global assessment; PS: Performance
status; SGA: Subjective global assessment; WHO: World Health Organization.
Silva et al. Nutrition Journal  (2015) 14:123 Page 7 of 8
Competing interests
The authors report no competing of interest.
Authors’ contributions
FRMS, ASRS, MGOAO and CSS contributed to the study design. FRMS
performed data collection. FRMS and JNF analyzed the data. FRMS, ASRS
and MGOAO wrote the article. All authors read and approved the final
manuscript.
Acknowledgements
We are grateful to all patients who participated in the study.
We thank the Research Support Fund (FAPE) of the IMIP, for financial support
for the research disclosure.
Author details
1Institute of Integrative Medicine Prof. Fernando Figueira (IMIP), Recife, PE,
Brazil. 2Federal University of Pernambuco (UFPE), Recife, PE, Brazil.
Received: 24 September 2015 Accepted: 8 December 2015
References
1. Instituto Nacional de Câncer José Alencar Gomes da Silva. Consenso
Nacional de Nutrição Oncológica. Serviço de Nutrição e dietética. 2015.
http://www1.inca.gov.br/inca/Arquivos/consensonacional-de-nutricao-
oncologica-2-edicao_2015_completo.pdf. Accessed 10 Mar 2015.
2. Wie GA, Cho YA, Kim SY, Kim SM, Bae JM, Joung H. Prevalence and risk
factors of malnutrition among cancer patients according to tumor location
and stage in the National Cancer Center in Korea. Nutrition. 2010. doi:10.
1016/j.nut.2009.04.013.
3. Pressoir M, Desne S, Berchery D, Rossignol G, Poiree B, Meslier M, et al.
Prevalence, risk factors and clinical implications of malnutrition in French
Comprehensive Cancer Centre. British Journal of Cancer. 2010;102(6):966–971.
4. Wu BW, Yin T, Cao WX, Gu ZD, Wang XJ, Yan M, et al. Clinical application of
subjective global assessment in Chinese patients with gastrointestinal
cancer. World J Gastroenterol. 2009. doi:10.3748/wjg.15.3542.
5. Waitzberg DL, Caiaffa WT, Correia MI. Hospital malnutrition: the Brazilian
National Survey (IBRANUTRI): a study of 4000 patients. Nutrition. 2001;17(7/8):
573–580.
6. Correia MI, Campos AC. Prevalence of hospital malnutrition in Latin
America: the multicenter ELAN study. Nutrition. 2003. doi:10.1016/
S0899-9007(03)00168-0.
7. González SS, Sobrino PS, Álvarez JAC, Villarroel PG, Fernández CP.
Parámetros antropométricos en la evaluación de la malnutrición en
pacientes oncológicos hospitalizados; utilidad del índice de masa
corporal y del porcentaje de pérdida de peso. Nutr Hosp. 2013.
doi:10.3305/nh.2013.28.3.6369.
8. Datema FR, Ferrier MB, de Jong RJ B. Impact of severe malnutrition on
short-term mortality and overall survival in head and neck cancer. Oral
Oncol. 2011. doi:10.1016/j.oraloncology.2011.06.510.
9. Mangar S, Slevin N, Mais K, Sykes A. Evaluating predictive factors for
determining enteral nutrition in patients receiving radical radiotherapy for
head and neck cancer: a retrospective review. Radiotherapy and Oncology.
2006. doi:10.1016/j.radonc.2005.12.014.
10. Ulibarri JI, Burgos R, Lobo G, Martínez MA, Planas M, A. Pérez de la cruz JL.
Recomendaciones sobre la evaluación del riesgo de desnutrición em los
pacientes hospitalizados. Nutr Hosp. 2009;24(4):467–72.
11. Associação Brasileira de Empresas e Pesquisa. Critério de classificação
econômica Brasil. 2011. http://www.abep.org/criterio-brasil. Accessed 20
Aug 2012.
12. Wold Health Organization. Physical status: the use and interpretation of
anthropometry. In: WHO technical report series. WHO expert committee.
1995. http://apps.who.int/iris/bitstream/10665/37003/1/WHO_TRS_854.pdf.
Accessed 24 Sept 2012.
13. Chumlea WC, Roche AF, Steinbaugh ML. Estimating stature from knee
height for persons 60 to 90 years of age. Journal of American Geriatric
Society. 1985. doi:10.1111/j.1532-5415.1985.tb02276.x.
14. Ottery FD. Definition of standardized nutritional assessment and
interventional pathways in oncology. Nutrition. 1996;12(1):S15–S19.
15. Gonzalez MC, Borges LR, Silveira DH, Assunção MCF, Orlandi SP. Validação
da versão em português da avaliação subjetiva global produzida pelo
próprio pacientes. Rev Bras Nutr Clin. 2010;25(2):102–8.
16. Sánchez-Lara K, Turcott J, Sosa-Sánchez R, Green-Renner D. Evaluación del
estado de nutrición en pacientes con câncer. Revista de Endocrinología y
Nutrición. 2008;16(4):165–71.
17. World Health Organization. Encuesta multicentrica: salud, bien estar y
envejecimiento (SABE) en América Latina y el Caribe. In: Anales da 36ª
Reunión del Comité Asesor de Investigaciones em salud. 2001.
18. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al.
Toxicity and response criteria of the Eastern Cooperative Oncology Group.
Am J ClinOncol. 1982;5(6):649–55.
19. Bozzetti F, Mariani L, LoVullo S. The nutritional risk in oncology: a study of
1,453 cancer outpatients. Support Care Cancer. 2012. doi:10.1007/s00520-
012-1387-x.
20. Sorensen JB, Klee M, Palshof T, Hansen HH. Performance status assessment in
cancer patients. An inter-observer variability study. Br. J. Cancer. 1993;67:773–775.
21. Borges NP, Silva BA, Cohen C, Filho PEP, Medeiros FJ. Comparison of the
nutritional diagnosis, obtained through different methods and indicators, in
patients with cancer. Nutr Hosp. 2009;24(1):51–5.
22. Bauer J, Capra S, Ferguson M. Use of the scored Patient-Generated
Subjective Global Assessment (PG-SGA) as a nutrition assessment tool in
patients with cancer. European Journal of Clinical Nutrition. 2002. doi:10.
1038/sj.ejcn.1601412.
23. Colling C, Durval PA, Silveira DH. Pacientes submetidos a quimioterapia:
avaliação nutricional prévia. Revista Brasileira de Cancerologia.
2012;58(4):611–7.
24. Destky AS, McLaughlin RJ, Baker JP, Johnston N, Whittaker S, Mendelson RA,
et al. What is subjective global assessment of nutritional status?. JPEN. 1987;
11(1):8–13.
25. Aquino RC, Philippi ST. Identificação de fatores de risco de desnutrição em
pacientes internados. Rev Assoc Med Bras. 2011;57(6):637–64.
26. Martin L, Watanabe S, Fainsinger R, Lau F, Ghosh S, Quan H, et al.
Prognostic factors in patients with advanced cancer: use of the patient-
generated subjective global assessment in survival prediction. J Clin Oncol.
2010. doi:10.1200/JCO.2009.27.1916.
27. Gioulbasanis I, Baracos VE, Giannousi Z, Xyrafas A, Martin L, Georgoulias V, et
al. Baseline nutritional evaluation in metastatic lung cancer patients: mini
nutritional assessment versus weight loss history. Ann Oncol. 2011. doi:10.
1093/annonc/mdq440.
28. Kolahdooz F, Mathe N, Katunga LA, Beck L, Sheehy T, Corriveau A, et al.
Smoking and dietary inadequacy among Inuvialuit women of child
bearing age in the Northwest Territories, Canada. Nutrition Journal.
2013. doi:10.1186/1475-2891-12-27.
29. Organização Mundial de Saúde. Tabagismo e Saúde nos Países em
desenvolvimento. Banco Mundial para a Mesa Redonda de Alto Nível sobre
Controle do Tabagismo e Políticas de Desenvolvimento. 2003. http://bvsms.
saude.gov.br/bvs/publicacoes/inca/tabagismo_saude.pdf. Accessed 9 Jan 2014.
30. Oliveira MR, Fogaça KC, Leandro-Merhi VA. Nutritional status and functional
capacity of hospitalized elderly. Nutr J. 2009. doi:10.1186/1475-2891-8-54.
31. Chang PH, Yeh KY, Huang JS, Lai CH, Wu TH, Lan YJ, et al. Pretreatment
performance status and nutrition are associated with early mortality of locally
advanced head and neck cancer patients undergoing concurrent
chemoradiation. Eur Arch Otorhinolaryngol. 2013. doi:10.1007/s00405-012-2290-2.
32. Griggs JJ, Sorbero ME, Lyman GH. Undertreatment of obese women
receiving breast cancer chemotherapy. Arch Intern Med. 2005. doi:10.1001/
archinte.165.11.1267.
33. McTiernan A. Obesity and cancer: the risks, science, and potential
management strategies. Oncology. 2005;19:871–81.
34. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al.
Sarcopenia: European consensus on definition and diagnosis. Age and
Ageing. 2010. doi:10.1093/ageing/afq034.
35. Prado CMM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L, et al.
Prevalence and clinical implications of sarcopenic obesity in patients with
solid tumours of the respiratory and gastrointestinal tracts: a population-
based study. Lancet Oncol. 2008. doi:10.1016/S1470-2045(08)70153-0.
Silva et al. Nutrition Journal  (2015) 14:123 Page 8 of 8
